Keywords: Takeda, Daxas, COPD, Merck & Co, Actos law suits

Takeda ends Daxas co-promotion with MSD; Actos law suits

Article | 03 January 2012

Print This

Japan’s largest drugmaker, Takeda Pharmaceuticals (TYO: 4502) says that it has reached a mutual agreement with US drug giant ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in